Home >> Industry News >> All The News
  • Also available via:

Quality Contrast Sensitivity Test Possiible with Tablets PDF
Submit Your News
Ophthalmology and Optometry
Monday, 06 July 2015

A contrast sensitivity test on a tablet demonstrated results similar to the traditional Pelli-Robson chart, according to research presented American Optometric Association’s annual meeting in Seattle, US.

"It is well established that the ability to detect and recognize low contrast targets often decreases earlier and more rapidly than high contrast vision in various ocular condition and diseases as well as in systemic and neurological disease," Rabin and colleagues wrote.

"With increasing longevity and emphases on home and remote medical monitoring, portable measures of contrast sensitivity (CS) are needed,” they said.

Researchers used a program from Innova Systems Inc. on a Windows 8 tablet to test contrast sensitivity in 27 normal subjects. As detailed in the abstract, single letters, in varying contrasts, appeared on the tablet, and participants used a touchscreen to indicate which letter they had seen. They compared the results of the tablet test to results of the Pelli-Robson chart test.

"There was no significant difference between test and subject eye," the researchers reported. "Mean differences between tests were less than one letter read correctly."

ODMA|2015 Awards of Excellence Results Are In... PDF
Submit Your News
Australian News
Saturday, 04 July 2015

ODMA just announced during their Gala Dinner that the winners of the awards are as follows:

Category Women's Optical Frames: Eyes Right Optical with Face a Face Bocca Tatoo

Category Men's Optical Frames: LOGO Australia with Tag Heuer Eyewear Reflex 3

Category Women's Sunglasses: Fritz Frames with Lorikeet

Category Men's Sunglasses: Bolle Serengeti Eyewear with Convertible Collection - Enzo & Palmin

Category Children's Frames: Aviva Optical with Nano Vista Nano Arcade

Category Sports Eyewear: Maui Jim with Waterman

Category Lens Design: Hoya Lens Australia with Hoyalux iD Mystyle V+

Category Lens Treatment / Coating: Shamir with Glacier Plus

Category Equipment: Device Technologies with Topcon 3D OCT-I Maestro

Category Product Environment: Essilor with Crizal UV

Best Modular Stand: Black Lily Imports

Best Custom Stand - Small: LBJ Optical

Best Custom Stand - Large: Eyes Right Optical

Rep of the year for New Zealand: Vineet Chauhan of Essilor

Rep of the year for QLD and NT: Bonnie Smith of Maui  Jim

Rep of the year for WA: Natalie Alcock of Eyes Right Optical

Rep of the year for VIC, TAS and SA: Gary Jones of HOYA Lens Australia

Rep oc the year for NSW and ACT: Roslyn Boland of Rodenstock


ODMA 2015 Opens Its Doors Tomorrow PDF
Submit Your News
Australian News
Thursday, 02 July 2015

ODMA 2015Australia's premier optical event will start tomorrow 03 July 2015. This year the event will be held for the second time in Brisbane. It will showcase of the best and latest products and services for the Australian optical industry. In the exhibition hall there will be 103 companies represented. There is also a conference program with a comprehensive CPD Program that will run concurrently at the exhibition, where delegates may earn up to 30 CPD points.

The second day of the ODMA2015 exhibition falls on 4 July; Independence Day in the US. As such, ODMA2015 has declared 4 July to be Independents Day, inviting visitors to celebrate their own independence. will be reporting live from the event.

The event will take place from July 3 to 5, 2015 at the Brisbane Convention & Exhibition Centre. For more information goto:

The Fred Hollows Foundation Partners with The Alice Springs Rotary Henley on Todd Regatta PDF
Submit Your News
Australian News
Wednesday, 01 July 2015

The Henley on Todd Regatta fundraising campaign aims to raise $100,000 for The Fred Hollows Foundation to contribute to the fight to end trachoma by 2020. The Regatta was started in 1962 when Rotary Club members met for a picnic at 16 Mile Creek outside of Alice Springs, where over a few beers they discussed ways to raise money for charity.

The Henley on Todd is one of the longest running fundraising events in Australia and is the Northern Territory’s most iconic event – synonymous with irreverence and that truly laconic outback humour. It has been so successful in creating that image, many people have forgotten what the Henley on Todd is, the major fundraising event for the three Rotary Clubs of Alice Springs.

Over the coming months leading up to the event on Saturday August 15 2015, individuals and organisations will be provided with a number of different ways that they can participate in the elimination of trachoma right here in Australia by 2020.

By going to you can not only join the fun of the Regatta, but help eliminate trachoma in Australia forever.

Study: Bionic Eye Safely Restores Vision PDF
Submit Your News
Ophthalmology and Optometry
Tuesday, 30 June 2015

Argus II patientThe three-year clinical trial results of the retinal implant popularly known as the "bionic eye", have proven the long-term efficacy, safety and reliability of the device that restores vision in those blinded by a rare, degenerative eye disease. The findings show that the Argus II significantly improves visual function and quality of life for people blinded by retinitis pigmentosa. They were published online recently in Ophthalmology, the journal of the American Academy of Ophthalmology.

The Argus II system was designed to help provide patients who have lost their sight due to retinitis pigmentosa with some useful vision. Through the device, patients with retinitis pigmentosa are able to see patterns of light that the brain learns to interpret as an image. The system uses a miniature video camera stored in the patient's glasses to send visual information to a small computerized video processing unit which can be stored in a pocket. This computer turns the image to electronic signals that are sent wirelessly to an electronic device implanted on the retina, the layer of light-sensing cells lining the back of the eye.

The Argus II received the US Food and Drug Administration (FDA) approval as a Humanitarian Use Device (HUD) in 2013, which is an approval specifically for devices intended to benefit small populations and/or rare conditions.

To further evaluate the safety, reliability and benefit of the device, a clinical trial of 30 people, aged 28 to 77, was conducted in the United States and Europe. All of the study participants had little or no light perception in both eyes. The researchers conducted visual function tests using both a computer screen and real-world conditions, including finding and touching a door and identifying and following a line on the ground. A Functional Low-vision Observer Rated Assessment (FLORA) was also performed by independent visual rehabilitation experts at the request of the FDA to assess the impact of the Argus II system on the subjects’ everyday lives, including extensive interviews and tasks performed around the home.

The visual function results indicated that up to 89 percent of the subjects performed significantly better with the device. The FLORA found that among the subjects, 80 percent received benefit from the system when considering both functional vision and patient-reported quality of life, and no subjects were affected negatively.

After one year, two-thirds of the subjects had not experienced device- or surgery-related serious adverse events. After three years, there were no device failures. Throughout the three years, 11 subjects experienced serious adverse events, most of which occurred soon after implantation and were successfully treated. One of these treatments, however, was to remove the device due to recurring erosion after the suture tab on the device became damaged.

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 309